title: Proliferative lupus nephritis in a patient with systemic lupus erythematosus and longstanding secondary amyloid nephropathy.
abstract: Secondary amyloidosis is an unusual complication of systemic lupus erythematosus (SLE). We report the case of a 60-year-old woman with SLE and secondary amyloidosis who developed class III proliferative lupus nephritis 13 years after the onset of amyloid nephropathy. The patient was treated with mycophenolate mofetil (1.5 g/day) with a significant improvement in proteinuria.
authors.affiliation: Department of Rheumatology, Hospital Clínic, Barcelona, Spain. jagomez@clinic.ub.es
authors.forename: Jose A
authors.initials: JA
authors.lastname: Gómez-Puerta
authors.forename: Ricard
authors.initials: R
authors.lastname: Cervera
authors.forename: Concepción
authors.initials: C
authors.lastname: Moll
authors.forename: Manel
authors.initials: M
authors.lastname: Solé
authors.forename: Antonio
authors.initials: A
authors.lastname: Collado
authors.forename: Raimon
authors.initials: R
authors.lastname: Sanmartí
mesh_terms: D000682:Amyloid / Q000378:metabolism; D000686:Amyloidosis / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007668:Kidney / Q000378:metabolism / Q000473:pathology*; D007678:Kidney Glomerulus / Q000378:metabolism / Q000473:pathology; D008181:Lupus Nephritis / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D011507:Proteinuria / Q000188:drug therapy; D016896:Treatment Outcome
chemical_list: D000682:Amyloid; D000894:Anti-Inflammatory Agents, Non-Steroidal; D009173:Mycophenolic Acid